TMCnet News
Zai Lab Announces Participation at Upcoming May ConferencesSHANGHAI, China, May 09, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that members of the senior management team will participate in four upcoming conferences in May. Details of the conferences are as follows:
Date: May 8-9, 2019
Date: May 14-16, 2019
Date: May 16-17, 2019
Location: Futian Shangri-La Hotel, Shenzhen Individuals may access more information on the Zai Lab website at www.zailaboratory.com under "Events & Presentations" in the "Investors" section. About Zai Lab Zai Lab (NASDAQ: ZLAB) is a China and US-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China's pharmaceutical market and addressing unmet medical needs. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners' and its own products in order to impact human health worldwide. Contact: Zai Lab Media: Nancie Steinberg / Robert Flamm Investors: Jill Steier |